Liberty Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $619K | Buy |
+4,814
| New | +$563K | 0.11% | 109 |
|
|
2025
Q4 | $534K | Sell |
5,069
-340
| -6% | -$31.9K | 0.1% | 114 |
|
|
2025
Q3 | $454K | Buy |
5,409
+200
| +4% | +$16.5K | 0.09% | 119 |
|
|
2025
Q2 | $412K | Hold |
5,209
| – | – | 0.08% | 120 |
|
|
2025
Q1 | $468K | Buy |
5,209
+277
| +6% | +$25.9K | 0.1% | 112 |
|
|
2024
Q4 | $491K | Hold |
4,932
| – | – | 0.11% | 112 |
|
|
2024
Q3 | $560K | Hold |
4,932
| – | – | 0.12% | 106 |
|
|
2024
Q2 | $611K | Buy |
4,932
+641
| +15% | +$82.6K | 0.14% | 98 |
|
|
2024
Q1 | $566K | Hold |
4,291
| – | – | 0.14% | 103 |
|
|
2023
Q4 | $468K | Hold |
4,291
| – | – | 0.12% | 108 |
|
|
2023
Q3 | $442K | Sell |
4,291
-192
| -4% | -$20.7K | 0.13% | 103 |
|
|
2023
Q2 | $517K | Hold |
4,483
| – | – | 0.16% | 98 |
|
|
2023
Q1 | $477K | Hold |
4,483
| – | – | 0.16% | 98 |
|
|
2022
Q4 | $497K | Hold |
4,483
| – | – | 0.17% | 98 |
|
|
2022
Q3 | $386K | Hold |
4,483
| – | – | 0.14% | 100 |
|
|
2022
Q2 | $409K | Sell |
4,483
-115
| -3% | -$10.2K | 0.15% | 98 |
|
|
2022
Q1 | $377K | Hold |
4,598
| – | – | 0.11% | 107 |
|
|
2021
Q4 | $352K | Hold |
4,598
| – | – | 0.1% | 111 |
|
|
2021
Q3 | $345K | Hold |
4,598
| – | – | 0.1% | 105 |
|
|
2021
Q2 | $358K | Sell |
4,598
-811
| -15% | -$60.3K | 0.11% | 106 |
|
|
2021
Q1 | $398K | Sell |
5,409
-93
| -2% | -$6.86K | 0.14% | 100 |
|
|
2020
Q4 | $429K | Buy |
+5,502
| New | +$421K | 0.16% | 97 |
|
|
2020
Q2 | $448K | Sell |
6,071
-1,048
| -15% | -$78.9K | 0.19% | 84 |
|
|
2020
Q1 | $523K | Sell |
7,119
-218
| -3% | -$17.1K | 0.27% | 70 |
|
|
2019
Q4 | $637K | Buy |
7,337
+326
| +5% | +$26.8K | 0.26% | 75 |
|
|
2019
Q3 | $563K | Buy |
7,011
+349
| +5% | +$28K | 0.25% | 77 |
|
|
2019
Q2 | $533K | Sell |
6,662
-147
| -2% | -$11.3K | 0.24% | 83 |
|
|
2019
Q1 | $540K | Buy |
6,809
+193
| +3% | +$14.4K | 0.27% | 72 |
|
|
2018
Q4 | $482K | Buy |
6,616
+238
| +4% | +$16.8K | 0.3% | 69 |
|
|
2018
Q3 | $432K | Sell |
6,378
-243
| -4% | -$15.5K | 0.23% | 80 |
|
|
2018
Q2 | $384K | Hold |
6,621
| – | – | 0.22% | 82 |
|
|
2018
Q1 | $344K | Sell |
6,621
-74
| -1% | -$4K | 0.21% | 87 |
|
|
2017
Q4 | $375K | Hold |
6,695
| – | – | 0.2% | 89 |
|
|
2017
Q3 | $408K | Buy |
6,695
+89
| +1% | +$5.4K | 0.22% | 91 |
|
|
2017
Q2 | $393K | Sell |
6,606
-845
| -11% | -$51.4K | 0.24% | 86 |
|
|
2017
Q1 | $452K | Buy |
7,451
+681
| +10% | +$41.3K | 0.27% | 81 |
|
|
2016
Q4 | $395K | Hold |
6,770
| – | – | 0.26% | 81 |
|
|
2016
Q3 | $403K | Buy |
6,770
+1,939
| +40% | +$113K | 0.26% | 79 |
|
|
2016
Q2 | $266K | Buy |
+4,831
| New | +$257K | 0.18% | 97 |
|
|
2015
Q3 | – | Sell |
-4,285
| Closed | -$233K | – | 95 |
|
|
2015
Q2 | $233K | Buy |
4,285
+152
| +4% | +$8.53K | 0.16% | 97 |
|
|
2015
Q1 | $227K | Buy |
4,133
+209
| +5% | +$11.8K | 0.15% | 98 |
|
|
2014
Q4 | $213K | Hold |
3,924
| – | – | 0.15% | 98 |
|
|
2014
Q3 | $222K | Hold |
3,924
| – | – | 0.16% | 94 |
|
|
2014
Q2 | $217K | Sell |
3,924
-140
| -3% | -$7.64K | 0.15% | 96 |
|
|
2014
Q1 | $220K | Buy |
+4,064
| New | +$210K | 0.16% | 96 |
|
Other funds holding MRK
ECSS
Liberty Capital Management's MRK Position: Q2 2026 in Review
Liberty Capital Management opened a new position in Merck (MRK) in Q2 2026: 4,814 shares worth $619K. The stake represents 0.11% of the portfolio and ranks #109 among its holdings. This is a return to the name: Liberty Capital Management previously reported a position in MRK as recently as Q4 2025.
Liberty Capital Management first reported a position in MRK in Q1 2014 and has held it in 45 quarters since. The position peaked at $637K in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Liberty Capital Management held 4,814 shares of Merck worth $619K as of Q2 2026.
- Merck was a new Liberty Capital Management position in Q2 2026.
- Merck made up 0.11% of Liberty Capital Management's portfolio in Q2 2026, its #109 holding.
- Liberty Capital Management first reported a position in Merck in Q1 2014 and has held it in 45 quarters since.
- Liberty Capital Management's Merck position peaked at $637K in Q4 2019.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Liberty Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.